{'fraction_non_alphanumeric': 0.018315018315018316, 'fraction_numerical': 0.005494505494505495, 'mean_word_length': 6.012820512820513, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Validation of a nomogram for predicting survival after resection for adenocarcinoma of the pancreas

Nomograms are statistical tools providing the overall probability of a specific outcome; they have shown better individual discrimination than the tumour node metastasis staging system in several cancers. The pancreatic nomogram, originally developed in the Memorial Sloan–Kettering Cancer Center (MSKCC) in the USA, combines clinicopathological and operative data to predict disease‐specific survival at 1, 2 and 3 years from initial resection.